Viridian Therapeutics, Inc.\DE (VRDN) EBT Margin (2016 - 2025)
Historic EBT Margin for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to 49.67%.
- Viridian Therapeutics, Inc.\DE's EBT Margin rose 888968400.0% to 49.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 427.3%, marking a year-over-year increase of 846352800.0%. This contributed to the annual value of 89387.09% for FY2024, which is 136756200.0% down from last year.
- Per Viridian Therapeutics, Inc.\DE's latest filing, its EBT Margin stood at 49.67% for Q3 2025, which was up 888968400.0% from 134313.33% recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's EBT Margin ranged from a high of 49.67% in Q3 2025 and a low of 134313.33% during Q2 2025
- Moreover, its 5-year median value for EBT Margin was 66194.44% (2023), whereas its average is 53170.09%.
- Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's EBT Margin crashed by -649564700bps in 2023 and then soared by 888968400bps in 2025.
- Viridian Therapeutics, Inc.\DE's EBT Margin (Quarter) stood at 13526.17% in 2021, then crashed by -222bps to 43604.76% in 2022, then crashed by -113bps to 92861.11% in 2023, then fell by -19bps to 110809.72% in 2024, then skyrocketed by 100bps to 49.67% in 2025.
- Its last three reported values are 49.67% in Q3 2025, 134313.33% for Q2 2025, and 120711.11% during Q1 2025.